NYSE:ACTTAct II Global Acquisition Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Act II Global Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $10.79 -0.10 (-0.92 %) (As of 07/15/2020 04:00 PM ET) Add Compare Share Today's Range$10.17Now: $10.79▼$11.0850-Day Range$10.06MA: $10.47▼$11.2252-Week Range$9.20Now: $10.79▼$11.22Volume3.38 million shsAverage Volume756,656 shsMarket Capitalization$352.02 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsInstitutional OwnershipHeadlinesSocial Media Act II Global Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in consumer packaged goods and other consumables, and hospitality businesses. The company was incorporated in 2018 and is based in New York, New York.Read More Beat the Market (BTM) Rank™ 1.0 Analyst's Opinion Consensus RatingAct II Global Acquisition has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $10.00, Act II Global Acquisition has a potential downside of 7.3% from its current price of $10.79.Amount of Analyst CoverageAct II Global Acquisition has received no research coverage in the past 90 days. Previous Next 2.2 Community Rank Outperform VotesAct II Global Acquisition has received 4 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAct II Global Acquisition has received 5 “underperform” votes. (Add your “underperform” vote.)Community SentimentAct II Global Acquisition has received 55.56% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Act II Global Acquisition and other stocks. Vote “Outperform” if you believe ACTT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ACTT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAct II Global Acquisition does not currently pay a dividend.Dividend GrowthAct II Global Acquisition does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Act II Global Acquisition insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 1.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.64 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Shell Companies Sub-IndustryN/A SectorFinancial Services Current SymbolNYSE:ACTT Previous Symbol CUSIPN/A CIKN/A WebN/A Phone212-370-1300Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares32,625,000Market Cap$352.02 million Next Earnings DateN/A OptionableNot Optionable ACTT Rates by TradingView Receive ACTT News and Ratings via Email Sign-up to receive the latest news and ratings for ACTT and its competitors with MarketBeat's FREE daily newsletter. Act II Global Acquisition (NYSE:ACTT) Frequently Asked Questions How has Act II Global Acquisition's stock been impacted by COVID-19 (Coronavirus)? Act II Global Acquisition's stock was trading at $10.11 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ACTT stock has increased by 6.7% and is now trading at $10.79. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Act II Global Acquisition? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Act II Global Acquisition in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Act II Global Acquisition. What price target have analysts set for ACTT? 1 brokerages have issued 1 year target prices for Act II Global Acquisition's stock. Their forecasts range from $10.00 to $10.00. On average, they expect Act II Global Acquisition's share price to reach $10.00 in the next year. This suggests that the stock has a possible downside of 7.3%. View analysts' price targets for Act II Global Acquisition. Has Act II Global Acquisition been receiving favorable news coverage? Media coverage about ACTT stock has trended extremely negative recently, InfoTrie reports. The research group scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Act II Global Acquisition earned a media sentiment score of -4.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 3.0 out of 10, meaning that recent press coverage is unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Act II Global Acquisition. Who are some of Act II Global Acquisition's key competitors? Some companies that are related to Act II Global Acquisition include Spartan Energy (SPAQ), Graf Industrial (GRAF), Far Point Acquisition (BRPM), BOSTONHLD/PAR VTG FPD 0.01 (BIH), Mustang Energy (MUST), Amplitude Healthcare Acquisition (AMHCU), Andina Acquisition Corp II (ANDAU), AnPac Bio-Medical Science (GHIVU), Ayala Pharmaceuticals (ROCHU), Big Rock Partners Acquisition (BRPAU), CHP Merger (CHPMU), CIIG Merger (CIICU), CITIC Capital Acquisition (ESSCU), CITIC Capital Acquisition (NBACU) and Daseke (HCACU). View all competitors. Who are Act II Global Acquisition's key executives? Act II Global Acquisition's management team includes the following people: Mr. Irwin David Simon, Exec. Chairman (Age 62)Mr. John Carroll, CEO & Director (Age 60)Mr. Ira J. Lamel CPA, CPA, Chief Financial Officer (Age 72)Ms. Mary Celeste Anthes, Sr. VP of Bus. Devel. & Investor Relations (Age 61) What is Act II Global Acquisition's stock symbol? Act II Global Acquisition trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACTT." How do I buy shares of Act II Global Acquisition? Shares of ACTT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Act II Global Acquisition's stock price today? One share of ACTT stock can currently be purchased for approximately $10.79. How big of a company is Act II Global Acquisition? Act II Global Acquisition has a market capitalization of $352.02 million. How can I contact Act II Global Acquisition? The company can be reached via phone at 212-370-1300. This page was last updated on 7/15/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
